600285 羚锐制药
已收盘 11-05 15:00:00
资讯
新帖
简况
羚锐制药（600285）11月4日主力资金净卖出4990.99万元
证券之星 · 11-05 08:44
羚锐制药（600285）11月4日主力资金净卖出4990.99万元
羚锐制药（600285）11月3日主力资金净卖出1399.56万元
证券之星 · 11-04 08:18
羚锐制药（600285）11月3日主力资金净卖出1399.56万元
股市必读：羚锐制药新发布《羚锐制药2026年第三季度报告》
证券之星 · 11-02
股市必读：羚锐制药新发布《羚锐制药2026年第三季度报告》
图解羚锐制药三季报：第三季度单季净利润同比增长26.71%
证券之星 · 10-29
图解羚锐制药三季报：第三季度单季净利润同比增长26.71%
羚锐制药(600285)9月30日股东户数4.96万户，较上期增加20.25%
证券之星 · 10-29
羚锐制药(600285)9月30日股东户数4.96万户，较上期增加20.25%
羚锐制药（600285）10月28日主力资金净卖出1329.08万元
证券之星 · 10-29
羚锐制药（600285）10月28日主力资金净卖出1329.08万元
股市必读：羚锐制药（600285）10月26日董秘有最新回复
证券之星 · 10-27
股市必读：羚锐制药（600285）10月26日董秘有最新回复
羚锐制药（600285）10月23日主力资金净卖出870.32万元
证券之星 · 10-24
羚锐制药（600285）10月23日主力资金净卖出870.32万元
羚锐制药（600285）10月21日主力资金净卖出1708.26万元
证券之星 · 10-22
羚锐制药（600285）10月21日主力资金净卖出1708.26万元
羚锐制药（600285）10月15日主力资金净卖出6050.96万元
证券之星 · 10-16
羚锐制药（600285）10月15日主力资金净卖出6050.96万元
羚锐制药（600285）10月14日主力资金净卖出5310.23万元
证券之星 · 10-15
羚锐制药（600285）10月14日主力资金净卖出5310.23万元
羚锐制药（600285）10月9日主力资金净买入3010.11万元
证券之星 · 10-10
羚锐制药（600285）10月9日主力资金净买入3010.11万元
股市必读：羚锐制药新发布《羚锐制药关于大股东部分股份解除质押及再质押的公告》
证券之星 · 10-08
股市必读：羚锐制药新发布《羚锐制药关于大股东部分股份解除质押及再质押的公告》
羚锐制药（600285）股东河南羚锐集团有限公司质押515万股，占总股本0.91%
证券之星 · 09-30
羚锐制药（600285）股东河南羚锐集团有限公司质押515万股，占总股本0.91%
羚锐制药（600285）披露大股东部分股份解除质押及再质押公告，9月29日股价上涨0.27%
证券之星 · 09-29
羚锐制药（600285）披露大股东部分股份解除质押及再质押公告，9月29日股价上涨0.27%
股市必读：羚锐制药（600285）9月1日董秘有最新回复
证券之星 · 09-02
股市必读：羚锐制药（600285）9月1日董秘有最新回复
股市必读：羚锐制药（600285）8月27日董秘有最新回复
证券之星 · 08-28
股市必读：羚锐制药（600285）8月27日董秘有最新回复
股市必读：羚锐制药新发布《羚锐制药关于大股东部分股份质押的公告》
证券之星 · 08-24
股市必读：羚锐制药新发布《羚锐制药关于大股东部分股份质押的公告》
羚锐制药（600285）披露大股东部分股份质押公告，8月21日股价下跌1.26%
证券之星 · 08-21
羚锐制药（600285）披露大股东部分股份质押公告，8月21日股价下跌1.26%
羚锐制药（600285）股东河南羚锐集团有限公司质押430万股，占总股本0.76%
证券之星 · 08-21
羚锐制药（600285）股东河南羚锐集团有限公司质押430万股，占总股本0.76%
加载更多
公司概况
公司名称：
河南羚锐制药股份有限公司
所属行业：
医药制造业
上市日期：
2000-10-18
主营业务：
河南羚锐制药股份有限公司的主营业务是药品的研发、生产及销售。公司的主要产品是橡胶膏剂、片剂、胶囊剂、软膏剂、喷雾剂。
发行价格：
8.30
{"stockData":{"symbol":"600285","market":"SH","secType":"STK","nameCN":"羚锐制药","latestPrice":23.57,"timestamp":1793862000000,"preClose":23.36,"halted":0,"volume":14831027,"delay":0,"changeRate":0.009,"floatShares":566000000,"shares":567000000,"eps":1.459,"marketStatus":"已收盘","change":0.21,"latestTime":"11-05 15:00:00","open":23.36,"high":23.67,"low":23.03,"amount":347000000,"amplitude":0.0274,"askPrice":23.58,"askSize":29,"bidPrice":23.57,"bidSize":69,"shortable":0,"etf":0,"ttmEps":1.459,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793928600000},"marketStatusCode":5,"adr":0,"adjPreClose":23.36,"symbolType":"stock","openAndCloseTimeList":[[1793842200000,1793849400000],[1793854800000,1793862000000]],"highLimit":25.7,"lowLimit":21.02,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":567115486,"isCdr":false,"pbRate":3.87,"roa":"--","peRate":16.154901,"roe":"20.71%","epsLYR":1.34,"committee":-0.092006,"marketValue":13367000000,"turnoverRate":0.0262,"status":0,"floatMarketCap":13352000000},"requestUrl":"/m/hq/s/600285","defaultTab":"news","newsList":[{"id":"2681411097","title":"羚锐制药（600285）11月4日主力资金净卖出4990.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681411097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681411097?lang=zh_cn&edition=full","pubTime":"2026-11-05 08:44","pubTimestamp":1793839458,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月4日收盘，羚锐制药报收于23.36元，下跌0.97%，换手率4.08%，成交量23.12万手，成交额5.43亿元。近5日资金流向一览见下表：羚锐制药融资融券信息显示，融资方面，当日融资买入3378.02万元，融资偿还2942.53万元，融资净买入435.49万元。羚锐制药主营业务：药品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500010093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0070","BK0077","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680709729","title":"羚锐制药（600285）11月3日主力资金净卖出1399.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680709729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680709729?lang=zh_cn&edition=full","pubTime":"2026-11-04 08:18","pubTimestamp":1793751523,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月3日收盘，羚锐制药报收于23.59元，上涨4.57%，换手率4.43%，成交量25.08万手，成交额5.82亿元。近5日资金流向一览见下表：羚锐制药融资融券信息显示，融资方面，当日融资买入3212.31万元，融资偿还2462.71万元，融资净买入749.59万元。羚锐制药主营业务：药品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400010732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","600285","BK0239","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680029222","title":"股市必读：羚锐制药新发布《羚锐制药2026年第三季度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680029222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680029222?lang=zh_cn&edition=full","pubTime":"2026-11-02 00:57","pubTimestamp":1793552228,"startTime":"0","endTime":"0","summary":"公司公告汇总羚锐制药2026年第三季度报告羚锐制药2026年第三季度营业收入为9.92亿元，同比增长5.29%；利润总额为2.62亿元，同比增长27.22%；归属于上市公司股东的净利润为2.24亿元，同比增长26.71%。羚锐制药关于召开2026年第三季度业绩说明会的公告河南羚锐制药股份有限公司将于2026年11月20日14:00–15:00通过上证路演中心网络互动方式召开2026年第三季度业绩说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0188","BK0077","600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679409825","title":"图解羚锐制药三季报：第三季度单季净利润同比增长26.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679409825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679409825?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:37","pubTimestamp":1793273843,"startTime":"0","endTime":"0","summary":"证券之星消息，羚锐制药2026年三季报显示，前三季度公司主营收入31.4亿元，同比上升3.24%；归母净利润7.19亿元，同比上升10.43%；扣非净利润6.59亿元，同比上升8.85%；其中2026年第三季度，公司单季度主营收入9.92亿元，同比上升5.29%；单季度归母净利润2.24亿元，同比上升26.71%；单季度扣非净利润1.94亿元，同比上升19.16%；负债率43.35%，投资收益3359.05万元，财务费用-974.08万元，毛利率79.04%。财报数据概要请见下图:本文数据来源于羚锐制药2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900047771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679146470","title":"羚锐制药(600285)9月30日股东户数4.96万户，较上期增加20.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679146470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679146470?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:48","pubTimestamp":1793270900,"startTime":"0","endTime":"0","summary":"证券之星消息，近日羚锐制药披露，截至2026年9月30日公司股东户数为4.96万户，较6月30日增加8357.0户，增幅为20.25%。在中药行业个股中，羚锐制药股东户数低于行业平均水平，截至9月30日，中药行业平均股东户数为5.34万户。从股价来看，2026年6月30日至2026年9月30日，羚锐制药区间跌幅为2.06%，在此期间股东户数增加8357.0户，增幅为20.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900044312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","600285","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679449317","title":"羚锐制药（600285）10月28日主力资金净卖出1329.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679449317","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679449317?lang=zh_cn&edition=full","pubTime":"2026-10-29 08:52","pubTimestamp":1793235132,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月28日收盘，羚锐制药报收于19.99元，下跌1.53%，换手率1.16%，成交量6.55万手，成交额1.32亿元。近5日资金流向一览见下表：羚锐制药融资融券信息显示，融资方面，当日融资买入986.91万元，融资偿还499.69万元，融资净买入487.22万元，连续3日净买入累计2219.41万元。羚锐制药主营业务：药品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900015247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0188","BK0239","600285","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678158501","title":"股市必读：羚锐制药（600285）10月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2678158501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678158501?lang=zh_cn&edition=full","pubTime":"2026-10-27 02:55","pubTimestamp":1793040947,"startTime":"0","endTime":"0","summary":"截至2026年10月26日收盘，羚锐制药报收于20.6元，上涨1.38%，换手率1.24%，成交量7.02万手，成交额1.44亿元。董秘最新回复投资者： 董秘您好，想了解截至2025年末兼任董事长和总经理的熊伟的毕业院校。贵公司历史上是否与该院校有业务合作，后续有无合作意向？如人员信息已变化，烦请说明。当日关注点交易信息汇总：10月26日主力资金净流入1352.77万元，占总成交额9.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700003913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0239","BK0077","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677903474","title":"羚锐制药（600285）10月23日主力资金净卖出870.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677903474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677903474?lang=zh_cn&edition=full","pubTime":"2026-10-24 08:27","pubTimestamp":1792801664,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月23日收盘，羚锐制药报收于20.32元，下跌0.97%，换手率1.79%，成交量10.15万手，成交额2.08亿元。10月23日的资金流向数据方面，主力资金净流出870.32万元，占总成交额4.18%，游资资金净流出718.58万元，占总成交额3.45%，散户资金净流入1588.9万元，占总成交额7.63%。近5日资金流向一览见下表：羚锐制药融资融券信息显示，融资方面，当日融资买入1134.16万元，融资偿还745.26万元，融资净买入388.9万元。羚锐制药主营业务：药品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400007080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600285","BK0239","BK0070","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677862469","title":"羚锐制药（600285）10月21日主力资金净卖出1708.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677862469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677862469?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:31","pubTimestamp":1792629091,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月21日收盘，羚锐制药报收于20.65元，下跌2.5%，换手率1.74%，成交量9.85万手，成交额2.05亿元。10月21日的资金流向数据方面，主力资金净流出1708.26万元，占总成交额8.33%，游资资金净流出1139.53万元，占总成交额5.56%，散户资金净流入2847.79万元，占总成交额13.89%。近5日资金流向一览见下表：羚锐制药融资融券信息显示，融资方面，当日融资买入792.1万元，融资偿还774.44万元，融资净买入17.67万元。羚锐制药主营业务：药品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200007012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0070","600285","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675559500","title":"羚锐制药（600285）10月15日主力资金净卖出6050.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675559500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675559500?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:15","pubTimestamp":1792109755,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月15日收盘，羚锐制药报收于21.23元，上涨0.52%，换手率3.02%，成交量17.12万手，成交额3.64亿元。近5日资金流向一览见下表：羚锐制药融资融券信息显示，融资方面，当日融资买入1186.15万元，融资偿还3355.37万元，融资净偿还2169.22万元。融券方面，融券卖出6200.0股，融券偿还1.16万股，融券余量28.95万股，融券余额614.61万元。羚锐制药主营业务：药品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600007140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","600285","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675375682","title":"羚锐制药（600285）10月14日主力资金净卖出5310.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675375682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675375682?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:14","pubTimestamp":1792023274,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，羚锐制药报收于21.12元，上涨3.89%，换手率3.42%，成交量19.35万手，成交额4.06亿元。10月14日的资金流向数据方面，主力资金净流出5310.23万元，占总成交额13.09%，游资资金净流入1127.42万元，占总成交额2.78%，散户资金净流入4182.81万元，占总成交额10.31%。近5日资金流向一览见下表：羚锐制药融资融券信息显示，融资方面，当日融资买入1656.83万元，融资偿还2669.47万元，融资净偿还1012.64万元。羚锐制药主营业务：药品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500006778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0239","BK0188","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674605358","title":"羚锐制药（600285）10月9日主力资金净买入3010.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674605358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674605358?lang=zh_cn&edition=full","pubTime":"2026-10-10 08:20","pubTimestamp":1791591646,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，羚锐制药报收于19.66元，上涨3.04%，换手率2.55%，成交量14.44万手，成交额2.82亿元。近5日资金流向一览见下表：羚锐制药融资融券信息显示，融资方面，当日融资买入1327.68万元，融资偿还1891.15万元，融资净偿还563.47万元。羚锐制药主营业务：药品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101000003925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","600285","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673012213","title":"股市必读：羚锐制药新发布《羚锐制药关于大股东部分股份解除质押及再质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673012213","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673012213?lang=zh_cn&edition=full","pubTime":"2026-10-08 02:26","pubTimestamp":1791397572,"startTime":"0","endTime":"0","summary":"公司公告汇总羚锐制药关于大股东部分股份解除质押及再质押的公告河南羚锐集团有限公司持有公司股份121,817,898股，占总股本21.48%。本次解除质押9,100,000股，占其所持股份7.47%，占公司总股本1.60%；随后再质押5,150,000股，占其所持股份4.23%，占公司总股本0.91%，质押用途为经营流动资金周转。变动后，羚锐集团累计质押33,280,300股，占其持股数量27.32%，占公司总股本5.87%；羚锐集团及其一致行动人合计质押股份占其持股总数26.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0239","600285","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671227928","title":"羚锐制药（600285）股东河南羚锐集团有限公司质押515万股，占总股本0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671227928","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671227928?lang=zh_cn&edition=full","pubTime":"2026-09-30 12:27","pubTimestamp":1790742443,"startTime":"0","endTime":"0","summary":"证券之星消息，羚锐制药9月30日公开信息显示，股东河南羚锐集团有限公司向中信银行股份有限公司信阳分行、中国工商银行股份有限公司新县支行合计质押515.0万股，占总股本0.91%。质押详情见下表：截止本公告日，股东河南羚锐集团有限公司已累计质押股份3328.03万股，占其持股总数的27.32%。羚锐制药主营业务：药品的研发、生产和销售。本文数据来源于羚锐制药公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000017591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0070","BK0239","600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671484572","title":"羚锐制药（600285）披露大股东部分股份解除质押及再质押公告，9月29日股价上涨0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671484572","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671484572?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:31","pubTimestamp":1790692278,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，羚锐制药报收于18.69元，较前一交易日上涨0.27%，最新总市值为105.99亿元。近日，羚锐制药发布《关于大股东部分股份解除质押及再质押的公告》。公告显示，河南羚锐集团有限公司持有公司股份121,817,898股，占公司总股本的21.48%。随后，羚锐集团将部分股份再质押，合计质押5,150,000股，占其所持股份的4.23%，占公司总股本的0.91%，质押用途为经营流动资金周转。本次变动后，羚锐集团累计质押股份33,280,300股，占其持股数量的27.32%，占公司总股本的5.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900040574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600285","BK0070","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886375","title":"股市必读：羚锐制药（600285）9月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664886375?lang=zh_cn&edition=full","pubTime":"2026-09-02 02:00","pubTimestamp":1788285650,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，羚锐制药报收于19.78元，上涨0.2%，换手率1.18%，成交量6.66万手，成交额1.32亿元。董秘最新回复投资者： 羚锐制药还要震荡多久董秘： 尊敬的投资者您好！股票走势受宏观经济、市场情绪等多重因素影响。公司目前生产经营正常，各项业务有序推进。当日关注点交易信息汇总：9月1日主力资金净流出502.44万元，占总成交额3.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200002151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0239","600285","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708079","title":"股市必读：羚锐制药（600285）8月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662708079?lang=zh_cn&edition=full","pubTime":"2026-08-28 03:47","pubTimestamp":1787860057,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，羚锐制药报收于19.89元，上涨1.02%，换手率1.53%，成交量8.66万手，成交额1.71亿元。董秘最新回复投资者： 董秘：您好！我咨询下公司的产品国外开拓的怎样？像东南亚一些地区，空间还是很大的。公司始终保持对各类业务机会的关注。当日关注点交易信息汇总：8月27日主力资金净流入785.62万元，占总成交额4.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800007417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0070","BK0077","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661724586","title":"股市必读：羚锐制药新发布《羚锐制药关于大股东部分股份质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661724586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661724586?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:48","pubTimestamp":1787507295,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，羚锐制药报收于19.54元，下跌1.26%，换手率1.54%，成交量8.72万手，成交额1.7亿元。公司公告汇总：羚锐制药大股东羚锐集团新增质押430万股，累计质押占公司总股本6.56%，用途为经营流动资金周转。公司公告汇总羚锐制药关于大股东部分股份质押的公告河南羚锐集团有限公司持有羚锐制药股份121,817,898股，占公司总股本的21.48%。本次质押4,300,000股后，累计质押股份37,230,300股，占其所持股份比例30.56%，占公司总股本比例6.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0070","BK0077","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661968372","title":"羚锐制药（600285）披露大股东部分股份质押公告，8月21日股价下跌1.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661968372","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661968372?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:09","pubTimestamp":1787321382,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，羚锐制药报收于19.54元，较前一交易日下跌1.26%，最新总市值为110.81亿元。该股当日开盘19.73元，最高19.73元，最低19.35元，成交额达1.7亿元，换手率为1.54%。近日，羚锐制药发布《关于大股东部分股份质押的公告》。公告显示，河南羚锐集团有限公司持有公司股份121,817,898股，占公司总股本的21.48%。本次质押4,300,000股后，累计质押股份37,230,300股，占其所持股份比例30.56%，占公司总股本比例6.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100045187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0188","BK0239","600285","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262508","title":"羚锐制药（600285）股东河南羚锐集团有限公司质押430万股，占总股本0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262508","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262508?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:41","pubTimestamp":1787308886,"startTime":"0","endTime":"0","summary":"证券之星消息，羚锐制药8月21日公开信息显示，股东河南羚锐集团有限公司向广发银行股份有限公司郑州商城支行合计质押430.0万股，占总股本0.76%。质押详情见下表：截止本公告日，股东河南羚锐集团有限公司已累计质押股份3723.03万股，占其持股总数的30.56%。羚锐制药主营业务：药品的研发、生产和销售。本文数据来源于羚锐制药公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100035097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600285","BK0188","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793917696885,"stockEarnings":[{"period":"1week","weight":0.1785},{"period":"1month","weight":0.2418},{"period":"3month","weight":0.0598},{"period":"6month","weight":0.1272},{"period":"1year","weight":0.1181},{"period":"ytd","weight":0.198}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河南羚锐制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49622人(较上一季度增加20.25%)","perCapita":"11416股","listingDate":"2000-10-18","address":"河南省信阳市新县将军路666号","registeredCapital":"56711万元","survey":" 河南羚锐制药股份有限公司的主营业务是药品的研发、生产及销售。公司的主要产品是橡胶膏剂、片剂、胶囊剂、软膏剂、喷雾剂。","listedPrice":8.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"羚锐制药(600285)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供羚锐制药(600285)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"羚锐制药,600285,羚锐制药股票,羚锐制药股票老虎,羚锐制药股票老虎国际,羚锐制药行情,羚锐制药股票行情,羚锐制药股价,羚锐制药股市,羚锐制药股票价格,羚锐制药股票交易,羚锐制药股票购买,羚锐制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"羚锐制药(600285)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供羚锐制药(600285)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}